Update on angiotensin AT2 receptors

Current Opinion in Nephrology and Hypertension

Volumn 26, Issue 2, 2017, Pages 91-96

  Carey, Robert M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

angiotensin; angiotensin receptors; blood pressure; hypertension; kidney function; kidney protection; natriuresis; sodium excretion

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN III; NITRIC OXIDE; SODIUM;

BLOOD PRESSURE REGULATION; GENE EXPRESSION REGULATION; HUMAN; KIDNEY FUNCTION; METABOLIC SYNDROME X; NATRIURESIS; NONHUMAN; OBESITY; POSITIVE FEEDBACK; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD PRESSURE; HYPERTENSION; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOTENSIN II; ANGIOTENSIN III; ANIMALS; BLOOD PRESSURE; HUMANS; HYPERTENSION; KIDNEY; NITRIC OXIDE; RECEPTOR, ANGIOTENSIN, TYPE 2; SODIUM;

EID: 85000925662     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0000000000000304     Document Type: Review

References (51)

1. Carey RM, Siragy HM. Newly recognized components of the renin-angio-tensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 2003; 24:261-271.
2. Carey RM. Newly discovered components and actions of the renin-angio-tensin system. Hypertension 2013; 62:818-822.
3. Ozono R, Wang Z-Q, Moore AF, et al. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 1997; 30:1238-1246.
4. Miyata N, Park F, Li XF, Cowley AW Jr. Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol Renal Physiol 1999; 277:F437-F446.
5. Siragy HM, Inagami T, Ichiki T, Carey RM. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A 1999; 96:6506-6510.
6. Gross V, Schunck WH, Honeck H, et al. Inhibition of pressure natriuresis in mice lacking the AT2 receptor. Kidney Int 2000; 57:191-202.
7. Obst M, Gross V, Janke J, et al. Pressure natriuresis in AT2 receptor-deficient mice with L-NAME hypertension. J Am Soc Nephrol 2003; 14:303-310.
8. Padia SH, Howell NL, Siragy HM, Carey RM. Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat. Hypertension 2006; 47:537-544.
9. Padia SH, Kemp BA, Howell NL, et al. Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptor-blocked rats. Hypertension 2007; 49:625-630.
10. Padia SH, Kemp BA, Howell NL, et al. Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats. Hypertension 2008; 51:460-465.
11. Hakam AC, Hussain T. Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis/diuresis in obese Zucker rats. Hypertension 2005; 45:270-275.
12. Hakam AC, Siddiqui AH, Hussain T. Renal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol 2006; 290:F503-F508.
13. Hakam AC, Hussain T. Angiotensin II AT2 receptors inhibit proximal tubular Na+K+ATPase activity via a NO/cGMP-dependent pathway. Am J Physiol Renal Physiol 2006; 290:F1430-F1436.
14. Hakam AC, Hussain T. Angiotensin type 2 receptor agonist directly inhibits proximal tubule sodium pump activity in obese but not lean Zucker rats. Hypertension 2006; 47:1117-1124.
15. Ali Q, Hussain T. AT2 receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats. Hypertens Res 2012; 35:654-660.
16. Kemp BA, Bell JF, Rottkamp DM, et al. Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors. Hypertension 2012; 60:387-395.
17. Johnson MD, Malvin RL. Stimulation of renal sodium reabsorption by angio-tensin II. Am J Physiol 1977; 232:F298-F306.
18. van der Mark J, Kline RL. Altered pressure natriuresis in chronic angiotensin II hypertension in rats. Am J Physiol 1994; 266:R739-R748.
19. Mattson DL, Raff H, Roman RJ. Influence of angiotensin II on pressure natriuresis and renal hemodynamics in volume-expanded rats. Am J Physiol 1991; 260:R1200-1209.
20. Wan Y, Wallinder C, Plouffe B. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem 2004; 47:5995-6008.
21. Bosnyak S, Jones ES, Christopoulos A, et al. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin Sci (Lond) 2011; 121:297-303.
22. Kemp BA, Howell NL, Gildea JJ, et al. AT2 receptor activation induces natriuresis and lowers blood pressure. Circ Res 2014; 115:388-399.
23. Siragy HM, Jaffa AA, Margolius HS, Carey RM. Renin-angiotensin system modulates renal bradykinin production. Am J Physiol 1996; 271:R1090- R1095.
24. Siragy HM, Carey RM. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997; 100:264-269.
25. Yang S, Han Y, Zheng S, et al. Enhanced natriuresis and diuresis in Wistar rats caused by the costimulation of renal dopamine D3 and angiotensin II type 2 receptors. Am J Hypertens 2015; 28:1267-1276.
26. Salomone LJ, Howell NL, McGrath HE, et al. Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism. Hypertension 2007; 49:155-161.
27. Padia SH, Kemp BA, Howell NL, et al. Mechanisms of dopamine D(1) and angiotensin type 2 receptor interaction in natriuresis. Hypertension 2012; 59:437-445.
28. Kemp BA, Howell NL, Keller SR, et al. AT2 receptor activation prevents sodium retention and reduces blood pressure in angiotensin II-dependent hypertension. Circ Res 2016; 119:532-543.
29. Fouiquier S, Steckelings UM, Unger T. Impact of AT2 receptor agonist C21 on blood pressure and beyond. Curr Hypertens Rep 2012; 14:403-409.
30. Sumners C, de Kloet AD, Krause EG, et al. Angiotensin type 2 receptors: blood pressure regulation and end organ damage. Curr Opin Pharmacol 2015; 21:115-121.
31. Jones ES, Del Borgo MP, Kirsch JF, et al. A single beta-amino acid substitution to angiotensin II confers AT(2) receptor selectivity and vascular function. Hypertension 2011; 57:570-576.
32. Scheuer DA, Perrone MH. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure responses to angiotensin. Am J Physiol 1993; 264:R917-R923.
33. Del Borgo M, Wang Y, Bosnyak S, et al. b-Pro7 Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats. Clin Sci 2015; 129:505-513.
34. Jones ES, Vinh A, McCarthy CA, et al. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 2008; 120:292-316.
35. Chow BSM, Allen TJ. Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease. Clin Sci (Lond) 2016; 130:1307-1326.
36. Abadir PM, Carey RM, Siragy HM. Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice. Hypertension 2003; 42:600-604.
37. Milia AF, Gross V, Piehm R, et al. Normal blood pressure and renal function in mice lacking the bradykinin B(2) receptor. Hypertension 2001; 37:1473-1479.
38. Dao VT, Medini S, Bishna M, et al. Nitric oxide up-regulates endothelial expression of angiotensin II type 2 receptors. Biochem Pharmacol 2016; 112:24-36.
39. Hunley TE, Tamura M, Stoneking BJ, et al. The angiotensin type II receptor tonically inhibits angiotensin-converting enzyme in AT2 null mutant mice. Kidney Int 2000; 57:570-577.
40. Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension 1996; 28:1047-1054.
41. Siddiqui AH, Ali Q, Hussain T. Protective role of angiotensin II subtype 2 receptor in blood pressure increase in obese Zucker rats. Hypertension 2009; 53:256-261.
42. Ali Q, Wu Y, Hussain T. Chronic AT2 receptor activation attenuates renal AT1 receptor function and blood pressure in obese Zucker rats. Kidney Int 2013; 84:931-939.
43. Ali Q, Patel S, Hussain T. Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats. Am J Physiol Renal Physiol 2015; 308:F1379-F1385.
44. Benicky J, Hafko R, Sanchez-Lemus E, et al. Six commercially available angiotensin II AT2 receptor antibodies are non-specific. Cell Mol Neurobiol 2012; 32:1353-1365.
45. Hein L, Meinel L, Pratt RE, et al. Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol 1997; 11:1266-1277.
46. Widdop RE, Matrougui K, Levy BI, Henrion D. AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension 2002; 40:516-520.
47. Teschner M, Paczek L, Schaefer RM, Heidland A. Obese Zucker rat: potential role of intraglomerular proteolytic enzymes in the development of glomerulo-sclerosis. Res Exp Med (Berl) 1991; 191:129-135.
48. Rehman A, Leibowitz A, Yamamoto N, et al. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 2012; 59:291-299.
49. Matavelli LC, Siragy HM. AT2 receptor activities and pathophysiological implications. J Cardiovasc Pharmacol 2015; 65:226-232.
50. Matavelli LC, Zatz R, Siragy HM. A nonpeptide angiotensin II type 2 receptor agonist prevents renal inflammation in early diabetes. J Cardiovasc Pharm 2015; 65:371-376.
51. Patel S, Ali Q, Hussain T. Angiotensin II type 2-receptor agonist C21 reduces proteinuria and oxidative stress in kidney of high-salt-fed obese Zucker rats. Hypertension 2016; 67:906-915.